Formulary system of drug supply and its formation in the republic of tatarstan

Abstract

Currently, according to WHO, at least 70% of drugs on the world market are duplicates or are not vital drugs. A number of drugs have an unfavorable balance of risk and effect. According to indications, many new drugs do not meet the basic needs of the majority of the population; they are much more expensive than existing drugs. A stable trend in recent years on a global scale is an increase in the cost of drugs, according to WHO experts, by an average of 20% per year, and those that are most often used by the majority of the population (antiulcer, antihypertensive drugs and antibiotics) [1]. In such conditions, the problem of rational use of drugs becomes extremely urgent. In daily practice, doctors need to make the choice of a drug for a particular patient, thereby ensuring the maximum therapeutic effect at a reasonable cost. This choice of medicinal product must be scientifically based.

Keywords

Kazan Medical archive

References

[1] Де Врис Т.Р.Г.М., Хеннинг Р.Г., Хогерзейл Г.В. и др. Руководство по надлежащему назначению лекарств.— ВОЗ.—Программа действий по основным лекарственным средствам. — Женева, 1997.

[2] Мор Т., Быков А., Савелии Э. и др. Руководство по внедрению формулярной системы в лечебных учреждениях. — ВОЗ.— Проект рационального фармацевтического менеджмента. — Арлингтон—Москва, 1997.

[3] Формулярная система: Методологическое руководство по разработке и внедрен и ю/Под ред. Галиуллина Н.И., Сафиуллина Р.С., Газизовой Н.Т. и др. — Казань, 1999.

[4] British National Formulary, 37-th edition. — London, 1999.

[5] Doing more good than harm: the evaluation of health care interventions/ Eds. K.S. Warren, F. Mosteller. - N.-Y., 1993.

[6] The Patient in Focus—a strategy for pharmaceutical sector reform in newly independent states. — WHO/EURO, Copenhagen, 1998.

[7] Strategy group meeting report/WHO special project on pharmaceuticals in NIS. — WHO, Copenhagen, 1999.

RIGHTS & PERMISSIONS

Eco-Vector